NCT05930470

Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Auburn University · Academic / Other
• Sex: All
• Age: 60 Years
• Healthy volunteers: Accepted

Summary

Thirty (30) adults with limited physical function will be recruited to participate in a double-blind pilot randomized controlled crossover trial in which all participants will receive 12-weeks of twice weekly MMT treatment in the first (Phase 1) or second half (Phase 2) of the study period; during the control period, participants will receive sham treatment and will be blinded to the randomization.

Conditions

• Frailty

Interventions

Type	Name	Description
OTHER	Magnetic Mitohormesis Therapy	The MMT device that will be used in the trial will be the QuantumTx BIXEPS Fitness and Wellness. The apparatus will provide pulsed electromagnetic fields at flux densities 1.5 mT. During the treatment period, participants will receive PEMF therapy during two ten-minute sessions each week for a total of 12 weeks. The treatment period will be preceded or followed by 12 weeks of twice-weekly sham treatments depending on randomization.

Timeline

• Start date: 2023-04-26
• Primary completion: 2024-07-01
• Completion: 2024-12-30
• First posted: 2023-07-05
• Last updated: 2023-07-05

Locations

1 site across 1 country: United States